HCMT
BIIB icon

Highland Capital Management (Texas)’s Biogen BIIB Stock Holding History

Highland Capital Management (Texas)’s Portfolio BIIB Stock Details BIIB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q4 		– Sell
-600
Closed -$212K – 275
2018
Q3 		$212K Buy
+600
New +$207K 0.01% 300
2017
Q3 		– Sell
-9,025
Closed -$2.45M – 304
2017
Q2 		$2.45M Buy
+9,025
New +$2.39M 0.1% 130
2014
Q3 		– Sell
-15,448
Closed -$4.87M – 237
2014
Q2 		$4.87M Buy
15,448
+11,269
+270% +$3.39M 0.18% 98
2014
Q1 		$1.28M Sell
4,179
-535
-11% -$170K 0.05% 147
2013
Q4 		$1.32M Buy
+4,714
New +$1.22M 0.07% 98

Other funds holding BIIB

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $121B AUM 27.52% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Highland Capital Management (Texas)'s BIIB Position: Q4 2018 in Review

Highland Capital Management (Texas) sold out of Biogen (BIIB) in Q4 2018, closing a stake of 600 shares — an estimated $212K sold.

Highland Capital Management (Texas) first reported a position in BIIB in Q4 2013 and held it in 5 quarters. The position peaked at $4.87M in Q2 2014. 1,141 funds tracked by Wall St. Rank hold BIIB as of Q4 2018.

  • Highland Capital Management (Texas) reported no remaining Biogen position as of Q4 2018 after selling out during the quarter.
  • Highland Capital Management (Texas) sold 600 Biogen shares in Q4 2018, an estimated $212K.
  • Highland Capital Management (Texas) first reported a position in Biogen in Q4 2013 and held it in 5 quarters.
  • Highland Capital Management (Texas)'s Biogen position peaked at $4.87M in Q2 2014.
  • 1,141 funds tracked by Wall St. Rank held Biogen as of Q4 2018.

Based on Highland Capital Management (Texas)'s 13F filing for Q4 2018, filed 13 Feb 2019.